Atrial fibrillation and bisphosphonate therapy-Reference-Cited by-同舟云学术

Atrial fibrillation and bisphosphonate therapy

Published:2010-01 Issue:1 Volume:25 Page:2-10
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Pazianas Michael,Compston Juliet,Huang Christopher L-H

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference78 articles.

1. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go;JAMA.,2001

2. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation;Savelieva;Nat Clin Pract Cardiovasc Med.,2008

3. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study;Heeringa;Eur Heart J.,2006

4. Status of the epidemiology of atrial fibrillation;Kannel;Med Clin North Am.,2008

5. Drug Topics www.drugtopics.com/drugtopics/Pharmacy+Facts+And+Figures/Top-200-brand-name-drugs-by-units-in-2006/ArticleStandard/Article/detail/407649?contextCategoryId=7604

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: A meta-analysis and systematic review;Seminars in Arthritis and Rheumatism;2024-02

2. Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect;Pharmacological Research;2024-02

3. Strontium-Doped Mesoporous Bioactive Glass-Loading Bisphosphonates Inhibit Osteoclast Differentiation and Prevent Osteoporosis in Ovariectomized Mice;Coatings;2024-01-11

4. Bisphosphonates and Cardiac Arrhythmia: An Analysis of the FDA Adverse Event Reporting System (FAERS);2024

5. Zoledronic acid—Annual infusions;Diagnosis and Treatment of Osteoporosis;2024